The survival rate for bowel cancer patients in Oxfordshire is among the highest in England, figures show.

But at the start of Bowel Cancer Awareness Month, Bowel Cancer UK warned that survival levels could drop to those of a decade ago as a result of disruption during the pandemic.

Public Health England figures show adults aged between 15 and 99 in the NHS Oxfordshire clinical commissioning group area had an 83.8 per cent chance of surviving for one year when diagnosed with bowel cancer in 2018 – the most recent year available.

READ ALSO: End of life goodbyes must be prioritised

The survival rate of Oxfordshire patients is also among the highest in England, and above the average of 80.7 per cent.

Chief executive Genevieve Edwards said the disease is treatable and curable if diagnosed early, but almost half a million people in England are still waiting for a test to confirm if they have it.

She said: "Delays like this can lead to poorer outcomes for bowel cancer patients and potentially cost lives.

"The Government must increase endoscopy capacity in the NHS by providing urgent multi-year investment to grow its workforce, provide new equipment and improve pathways to bring waiting times under control, which will ultimately save more lives.”

A recent report by the Institute for Public Policy Research warned disruption to healthcare amid the pandemic could see bowel cancer survival rates return to those last seen in 2010.

READ ALSO: Athletes in Kidlington battle cold wind for Easter Monday road race

Ms Edwards added: "We know that NHS staff continue to work incredibly hard to keep cancer services going, but the severe disruption over the last 12 months has led to many people having their treatment delayed or cancelled, sometimes with devastating consequences."

Around six in 10 new cases of the disease are diagnosed in people aged 70 or over, according to the charity, but bowel cancer can affect anyone of any age.

Bowel Cancer Awareness Month, in April, is an annual campaign to increase the public's understanding of the UK’s second biggest cancer killer.